Safacto AF Injection 500IU In Pakistan | Topmalll.com

Safacto AF 500 IU is a recombinant coagulation Factor VIII replacement medicine used for the treatment and prevention of bleeding in people with Hemophilia A, a condition caused by insufficient Factor VIII. It replaces the missing clotting factor and helps restore the blood’s ability to form clots. Safacto AF is supplied as a lyophilized powder for preparation before intravenous administration.

Specifications:

• Brand: Safacto AF
• Active Ingredient: Recombinant Coagulation Factor VIII
• Strength: 500 IU
• Dosage Form: Lyophilized powder for injection
• Route: Intravenous (IV)
• Therapeutic Class: Blood coagulation factor
• Manufacturer: Saman Darou 8, Iran

Benefits:

Safacto AF provides Factor VIII replacement for patients with Hemophilia A. It can help control active bleeding episodes and may be used as prescribed to prevent bleeding or provide clotting-factor support around certain surgical procedures. Treatment can reduce the consequences of inadequate clotting when appropriate Factor VIII replacement is maintained.

How to Use:

Safacto AF should be reconstituted and administered intravenously by a qualified healthcare professional or by a patient/caregiver specifically trained to administer Factor VIII. The required dose depends on body weight, Factor VIII level, severity and location of bleeding, and the patient's clinical response. Do not determine or change the dose yourself. Regular monitoring may be required, particularly because some patients can develop Factor VIII inhibitors that reduce treatment effectiveness.